Spirotropane compounds and methods for the modulation of chemokine receptor activity
US7960403B2 · kind B2 · utility
3Cited by
3References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 9, 2005 |
| Grant date | Jun 14, 2011 |
| Priority date | — |
| Expiry date | Feb 1, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds according to formula (I):wherein A, R1, R2 and R3 are defined as defined herein, and the pharmaceutically acceptable salts, hydrates and solvates thereof, are useful for the modulation of CCR5 chemokine receptor activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.